Carlson Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-835,000
Closed -$32.8M – 173
2023
Q2
$32.8M Buy
+835,000
New +$29.5M 2.81% 7

Carlson Capital's ISEE Position: Q3 2023 in Review

Carlson Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 835,000 shares — an estimated $32.8M sold.

Carlson Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $32.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Carlson Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Carlson Capital sold 835,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $32.8M.
  • Carlson Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Carlson Capital's IVERIC bio, Inc. Common Stock position peaked at $32.8M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Carlson Capital's 13F filing for Q3 2023, filed 14 Nov 2023.